Related Experiment Videos
Glipizide-induced pigmented purpuric dermatosis
1University of Cincinnati, College of Medicine, Department of Dermatology, Ohio 45267-0523, USA. adamsbb@email.uc.edu
Journal of the American Academy of Dermatology
|October 27, 1999
Summary
Glipizide, an oral hypoglycemic agent, can cause pigmented purpuric dermatosis. This is the first reported case linking glipizide to this skin condition.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Pigmented purpuric dermatoses are a group of skin disorders characterized by purpura and hyperpigmentation.
- While various medications have been implicated, oral hypoglycemic agents have not been previously associated with this condition.
Observation:
- A case of a patient developing pigmented purpuric dermatosis is presented.
- The patient was reportedly taking glipizide, a common oral hypoglycemic medication.
Findings:
- The study identifies glipizide as a potential causative agent for pigmented purpuric dermatosis.
- This represents the first documented instance of an oral hypoglycemic agent inducing this dermatological reaction.
Implications:
- This finding expands the list of potential drug-induced causes for pigmented purpuric dermatosis.
- Clinicians should consider glipizide as a possible etiology in patients presenting with these symptoms.